Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast cancer progressing after anthracycline and taxane

被引：0
|
作者：
Ozdemir, Nuriye Yildirim [1 ]
Abali, Huseyin [1 ]
Oksuzoglu, Berna [1 ]
Budakoglu, Burcin [1 ]
Uncu, Dogan [1 ]
Guler, Tunc [1 ]
Zengin, Nurullah [1 ]
Hastanesi, Ankara Numune [1 ]
机构：
[1] Ankara Numune Hastanesi Med Onkol Klin, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer
    Pugliano, Lina
    de Azambuja, Evandro
    ONKOLOGIE, 2012, 35 (09): : 476 - 478
  • [42] Cisplatin navelbine versus cisplatin capecitabine in the treatment of metastatic breast cancer
    Hashem, T.
    al-Din, K. Kamal
    Mobarek, N.
    Al-Said, T.
    Al-Hassanin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] CISPLATIN VINORELBINE VERSUS CISPLATIN CAPECITABINE IN THE TREATMENT OF METASTATIC BREAST CANCER
    Mobarek, N. A.
    Hashem, T. A. M.
    ANNALS OF ONCOLOGY, 2009, 20 : 63 - 63
  • [44] Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
    Watanabe, J.
    Horiguchi, J.
    Masuda, N.
    Aogi, K.
    Sato, R.
    Tokudome, T.
    Peck, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] A phase I study of BMS-247550 in combination with capecitabine in patients with metastatic breast cancer previously treated with a taxane and an anthracycline
    Thomas, E
    Bunnell, CA
    Vahdat, LT
    Schwartsberg, LS
    Gralow, JR
    Whitaker, LM
    Peck, R
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S83 - S83
  • [46] Docetaxel (Taxotere®) plus cisplatin:: an active and well-tolerated combination in patients with advanced non-small cell lung cancer
    Le Chevalier, T
    Monnier, A
    Douillard, JY
    Ruffie, P
    Sun, XS
    Belli, L
    Ibrahim, N
    Bougon, N
    Bérille, J
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (13) : 2032 - 2036
  • [47] The combination of capecitabine and bevacizumab as treatment for metastatic breast cancer
    Gradishar, William J.
    CANCER INVESTIGATION, 2007, 25 : 3 - 4
  • [48] Capecitabine/vinorelbine:: An effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer
    Nole, Franco
    Catania, Chiara
    Munzone, Elisabetta
    Rocca, Andrea
    Verri, Elena
    Sanna, Giuseppina
    Ascione, Gilda
    Adamoli, Laura
    Zampino, Maria G.
    Minchella, Ida
    Goldhirsch, Aron
    CLINICAL BREAST CANCER, 2006, 6 (06) : 518 - 524
  • [49] Phase II study of irinotecan plus capecitabine in patients with anthracycline and taxane pretreated metastatic breast cancer
    Lee, K. S.
    Ro, J.
    Park, I. H.
    Kim, E. A.
    Nam, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Weekly paclitaxel:: an effective and well-tolerated treatment in patients with advanced breast cancer
    Lück, HJ
    Roché, H
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 : S15 - S30
12345